版本:
中国

BRIEF-Flex Pharma presents human efficacy data on FLX-787

April 19 Flex Pharma Inc:

* Flex Pharma presents human efficacy data on FLX-787 at the American Academy of neurology annual meeting

* Flex Pharma - data from first treatment exposure of 26 subjects showed statistically significant effect in reducing cramp frequency compared to placebo

* Phase 2 studies planned for flx-787 to initiate in us this summer in ALS and Charcot-Marie-Tooth Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐